Feng P, Catt K J, Knecht M
Endocrinology and Reproduction Research Branch, National Institutes of Health, Bethesda, Maryland 20892.
Endocrinology. 1988 Jan;122(1):181-6. doi: 10.1210/endo-122-1-181.
The effect of transforming growth factor-beta (TGF beta) on meiotic maturation was analyzed in oocytes from immature rats treated with PMSG. TGF beta accelerated the maturation of both follicle-enclosed oocytes and cumulus-oocyte complexes, as measured by an increase in the percentage of oocytes with germinal vesicle breakdown. Concentrations of the growth factor as low as 1 pM (25 pg/ml) increased oocyte maturation by 50% above control values, and 100 pM TGF beta caused a maximal 2-fold rise in the maturation rate. Germinal vesicle breakdown was significantly increased by TGF beta during the first 4 h of incubation, and stimulatory effects were observed as early as 1 h. However, by 8 h over 90% of the oocytes showed maturation in the absence or presence of TGF beta, indicating that the growth factor enhanced the spontaneous rate of oocyte development. TGF beta had no effect in denuded oocytes, demonstrating that the growth factor altered maturation through an action on the surrounding cumulus cells. Oocyte maturation was not accelerated by TGF beta in the presence of inhibitors of germinal vesicle breakdown, such as cAMP and hypoxanthine. Other growth factors, including IGF-I (50 ng/ml) and IGF-II (50 ng/ml), also stimulated oocyte maturation, while platelet-derived growth factor (100 ng/ml) and insulin (1 microgram/ml) had minimal effects on germinal vesicle breakdown. Although epidermal growth factor (EGF; 100 ng/ml) also increased the maturation of oocytes, lower concentrations of TGF beta (1-10 pM) suppressed EGF action by up to 30%. TGF beta, EGF, and insulin-like growth factors had minimal effects on cAMP production by cumulus-oocyte complexes. These results demonstrate that TGF beta and other growth factors are potent in vitro stimulators of oocyte maturation in the rat. Such effects of growth factors in vivo, in the presence of endogenous follicular factors and gonadotropic hormones, may regulate the selection and meiotic maturation of oocytes during follicular development. The rapidity of growth factor action in the oocyte provides a defined model to study signal transduction pathways of growth factors in relationship to their biological activity.
在经孕马血清促性腺激素(PMSG)处理的未成熟大鼠的卵母细胞中,分析了转化生长因子-β(TGF-β)对减数分裂成熟的影响。通过有生发泡破裂的卵母细胞百分比增加来衡量,TGF-β加速了卵泡包绕的卵母细胞和卵丘-卵母细胞复合体的成熟。低至1皮摩尔(25皮克/毫升)的生长因子浓度使卵母细胞成熟度比对照值提高了50%,100皮摩尔的TGF-β使成熟率最大提高了2倍。在孵育的最初4小时内,TGF-β显著增加了生发泡破裂,早在1小时就观察到了刺激作用。然而,到8小时时,超过90%的卵母细胞在有无TGF-β的情况下都显示出成熟,这表明生长因子提高了卵母细胞发育的自发速率。TGF-β对裸卵母细胞没有影响,表明生长因子通过作用于周围的卵丘细胞改变成熟过程。在存在生发泡破裂抑制剂如环磷酸腺苷(cAMP)和次黄嘌呤的情况下,TGF-β不会加速卵母细胞成熟。其他生长因子,包括胰岛素样生长因子-I(IGF-I,50纳克/毫升)和胰岛素样生长因子-II(IGF-II,50纳克/毫升),也刺激卵母细胞成熟,而血小板衍生生长因子(100纳克/毫升)和胰岛素(1微克/毫升)对生发泡破裂的影响最小。虽然表皮生长因子(EGF,100纳克/毫升)也增加了卵母细胞的成熟,但较低浓度的TGF-β(1-10皮摩尔)可将EGF的作用抑制高达30%。TGF-β、EGF和胰岛素样生长因子对卵丘-卵母细胞复合体产生cAMP的影响最小。这些结果表明,TGF-β和其他生长因子是大鼠卵母细胞成熟的有效体外刺激剂。在体内,在存在内源性卵泡因子和促性腺激素的情况下,生长因子的这种作用可能在卵泡发育过程中调节卵母细胞的选择和减数分裂成熟。生长因子在卵母细胞中的快速作用提供了一个明确的模型,用于研究生长因子与其生物学活性相关的信号转导途径。